Inactive Instrument

Insiders Organovo Holdings Inc Nyse

Equities

US68620A1043

End-of-day quote Nyse Other stock markets
- ^USD	-

Apr. 15	Organovo's fatty liver disease drug meets main goal in mid-stage study	RE
Apr. 15	Organovo Holdings, Inc. Announces Positive Phase 2 Results for FXR314 in Metabolic Dysfunction-Associated Steatohepatitis Showing Both Reduction in Liver Fat Content and Strong Safety and Tolerability Compared to Placebo	CI

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Organovo Holdings, Inc. Appoints vaidehi Joshi to the Board as Class I Director	22-03-10	CI
Organovo Holdings, Inc. Announces the Hiring of Curtis Tyree, PhD, as Sr. Vice President of Strategy and Business Development	22-02-18	CI
Organovo Holdings, Inc. Announces Executive Changes	21-10-06	CI
Organovo Holdings, Inc. Appoints Jonathan Lieber as President, Effective May 13, 2021	21-05-13	CI
Organovo Holdings, Inc. Announces Executive Changes	21-04-19	CI
Organovo Holdings, Inc. Announces Management Changes	20-09-17	CI
Organovo Holdings, Inc. Announces Board Changes	20-07-15	CI
Organovo Holdings, Inc. Announces Management Appointments	19-12-16	CI
Organovo Holdings, Inc. Appoints Carolyn Beaver as New Board Member	19-02-20	CI
Organovo Holdings, Inc. Appoints David Shapiro to the Board	18-12-06	CI
Organovo Holdings, Inc. Announces Resignation of Sharon Presnell as Chief Scientific Officer, Effective December 5, 2018	18-11-27	CI
Organovo Announces Appointment of Steven G. Hughes as Chief Medical Officer	18-08-01	CI
Organovo Holdings, Inc. Announces the Resignation of Eric David as Chief Strategy Officer and Executive Vice President of Preclinical Development, Effective December 12, 2017	17-12-01	CI
Organovo Holdings, Inc. Announces the Resignation of Keith Murphy from the Board of Directors	17-08-28	CI
Organovo Holdings, Inc. Announces Management Changes	17-04-11	CI
Organovo Holdings, Inc. Announces Board Appointments	16-08-18	CI
Organovo Holdings, Inc. Appoints Craig Kussman as Chief Financial Officer, Effective August 22, 2016	16-08-02	CI
Organovo Holdings, Inc. Announces Retirement of Richard Heyman from its Board	16-07-08	CI
Organovo Holdings, Inc. Announces Changes to the Management Team	16-04-05	CI
Organovo Holdings, Inc. Appoints Paul Gallant as General Manager of the in Vitro Tissue Service and Product Business	15-08-04	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Insiders Organovo Holdings Inc Nyse

Equities

US68620A1043

Insiders

Filters